Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions

Inclusion Criteria: * Subject is at least 21 and no older than 80 years of age. * Subject gives voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained. * Subject must comply with study procedures including follow-up visits. * Subject is willing to have SH lesions treated in a single treatment session and understands that their lesion(s) may undergo a second treatment session at a subsequent visit. * Subject must have a minimum of four SH lesions and up to 10 SH lesions to be treated and the subject must have at least two SH lesions located on each side of the face. * For study purposes, the SH lesions must be no greater than 2 mm in height and must not exceed 5 mm x 5 mm at their largest dimension. The subject's lesions cannot be located within the eye orbit, nose, or scalp. * Subject consents to have photographs taken of the SH lesion(s). * Subject agrees to refrain from using all other lesion removal products or treatments (e.g. retinols, retinoids, and exfoliating products) to the treated SH lesions or any new SH lesions during the study period. * Subject agrees to refrain from prolonged sun exposure during the study period. Exclusion Criteria: * Subject has an implantable electronic medical device.(i.e., pacemaker, implantable cardioverter defibrillator) * Subject has an active infection or history of infection in designated test area within 90 days prior to first treatment. * Subject is not willing or …